DG

Dragan Grabulovski

Acting CEO, Co-founder and Chairman at Araris Biotech AG

Zurich

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Life Sciences
Biotechnology
Pharmaceutical Industry
Antibodies
Protein Engineering
Strategic Planning
Drug Discovery
Due Diligence
Consulting
Advisory Boards
Management
Lifesciences
Cancer
Molecular Biology
Cell Biology
In Vitro
Protein Chemistry
Cell Culture
In Vivo
Immunology

Education

Lists including Dragan

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

AB
Araris Biotech AG

2019

  • Acting CEO

    2023

  • Co-founder and Chairman

    2019

MT
Memo Therapeutics AG

2017

  • Strategic Advisor

    2021

  • Acting Chairman

    2020 - 2021

  • Board Member

    2018 - 2020

  • Strategic Advisor

    2017 - 2018

PB
Pureos Bioventures

2021

  • Venture Partner

    2021

T
TopPharm

2018

  • Owner of pharmacy "TopPharm Apotheke Witikon"

    2018

Grabulovski Consulting Services

2015

  • CEO and founder

    2015

MA
Microcaps AG

2020 - 2023

  • Board Member

    2020 - 2023

BP
BIOMUNEX PHARMACEUTICALS

2016 - 2023

  • Board Observer

    2016 - 2023

EZ
ETH Zürich

2017 - 2023

  • Startup Coach

    2017 - 2023

Covagen, one of the Janssen Pharmaceutical Companies of Johnson & Johnson

2014 - 2015

  • CSO

    2014 - 2015

Covagen

2007 - 2014

  • CSO and co-founder

    2007 - 2014